-
-
-
-
-
-
-
RBC Capital Assumes Illumina (ILMN) at Outperform
-
-
-
-
-
-
-
Illumina (ILMN) PT Raised to $145 at Argus
-
-
-
-
-
-
-
Canaccord: 'Roche ups the ante with $150 genome and reusable chips (20x); may prove formidable vs. ILMN; HOLD'
-
-
-
-
-
-
-
Illumina (ILMN) Tops Q4 EPS by 13c, provides guidance
-
-
-
-
-
-
-
Illumina (ILMN) Sees Multiple Growth Levers Over 3-5 Years - Stifel
-
-
-
-
-
-
-
Illumina constellation technology identifies hard-to-detect genetic variants
-
-
-
-
-
-
-
Illumina launches protein prep assay for drug discovery research
-
414,174 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

